Chapter 122: Buying
Unlike Dr. Laura's neutral stance, Bill, who was in charge of the laboratory at this time, had a very bad expression.
After all, their laboratory is a scientific research institution that develops and treats AIDS, and it is also a laboratory of a commercial company. This type of laboratory is the most realistic.
The Ai Qingling launched by Qingye Medical is simply destroying their jobs. It would be strange if he could still be happy.
Holding several reports in his hands, Bill's face looked gloomy.
Although Aiqingling has relatively serious side effects, it can cure AIDS instead of requiring lifelong medication to control the disease.
In fact, many pharmaceutical companies nowadays do not like to develop radical cure drugs, but prefer to develop palliative drugs.
The reason is self-evident.
That's to make money.
Qingye Medical also has relieving drugs, but after discussions with Ma Chi, Liu Zhifan and others, they still felt it was necessary to launch a radical cure drug.
There are three purposes:
The first purpose is to quickly obtain funds and enhance the stability of financial resources; the second purpose is to quickly break out of the circle and make Qingye Medical famous; the third purpose is to gain a technological advantage over other pharmaceutical companies.
Although Qingye Medical has acquired a large number of medical supplies companies and pharmaceutical manufacturers in Hongsavadi, its scale is not small, but its fame is limited to within Hongsavadi.
The launch of the new test strips, Aiqingling and Rabies Killer this time is to expand the market and gain fame.
Drugs for relieving AIDS are produced by major European and American companies. In this field, even if Qingye Medical develops safer and cheaper drugs, it will not be able to obtain market access in Europe and the United States. At most, it can compete with Tianzhu generic drug companies in the market.
Therefore, Ma Chi and Liu Zhifan chose to change tracks. You European and American pharmaceutical companies drive gasoline cars, but I just drive airplanes.
Now Bill can see that Aoba Medical has sinister intentions.
European and American pharmaceutical companies can lobby various countries to prevent Qingye Medical's drugs from entering their markets, but for some regions, they have no way to completely control it.
For example, Siam.
The other party is right next to Hongsavadi. Even if someone in Siam is crazy and prohibits the entry of Qingye Medical's drugs, it cannot stop the smuggling by the people, or patients will go directly to Hongsavadi to buy them.
Given the custom of wearing gold and silver in various parts of the Indochina Peninsula, even if the patient does not have gold coins, he can directly use gold to purchase medicine.
…
Sure enough, when Chia Tai Company announced that it had a drug for sale that could cure AIDS .
In pharmacies across Siam owned by Chia Tai, the less than 1,000 boxes of Ai Qing Ling were quickly sold out. Even the retail price of 500,000 baht (150,000 RMB) per box did not stop the market's enthusiasm.
In Bangkok's underground black market.
On the top floor of a small bar, a gangster boss with tattoos all over his body was sitting with his legs crossed, smoking a cigarette: "Huh... Along , how many boxes did you receive?"
"I received 12 boxes, and now the price has risen to around 700,000." My younger brother A Long quickly replied.
The boss threw the cigarette butt into the milk tea cup and said, "Ship it as soon as possible, don't let it get in your hands. I guess Xie's will increase the import quantity soon."
The man in a suit who was eating fried noodles wiped his mouth and said, "Brother, don't focus on this small business in Bangkok. We should find a way to contact people in Cambodia, Annan, and Malaysia, and then sell the domestic Ai Qingling to them. After all, these places have not approved the import of Ai Qingling."
"Huh? You're the one who thinks quickly, brother." The eldest brother felt that this business was profitable.
The man in the suit also reminded: "Don't forget that the retail price of Hongshawadi is only 50,000 gold yuan. The cost price of Xie's import must not be high. If we can get in touch with Qingye Group, we may be able to get a cheaper price."
"But Xie has obtained the exclusive agency rights." The boss was a little worried.
The man in the suit shrugged. "His exclusive agency rights are only in Siam, not in other regions. We can definitely contact the Golden Triangle, take the Mekong River, and enter Lancang and Cambodia."
The boss, who was thirsty for the huge profits, immediately mobilized his troops and began to plan the smuggling of Ai Qingling.
After all, this medicine is not flour, so the risk is much smaller.
…
When Charoen Pokphand Company saw the sales of Ai Qingling, they knew that one thousand boxes of Ai Qingling could bring them a profit of 300 million baht, so they didn't care about exhausting the resources.
Without even a few days' rest, Xie Bin hurriedly flew to Yangon.
After quickly passing the comprehensive security check at Yangon Airport, Xie Bin went straight to Qingye Medical's office building.
“It’s a great honor to see Ms. Tian again.”
Tian Hemeng probably guessed the other party's intention, and replied with a smile: "Let's be direct! If you need anything, just say it directly."
"This time, I am here on behalf of Zhengda Company to purchase 10,000 boxes of Ai Qingling and 100 boxes of Rabies Killer from your company."
"Sure, but it will take some time to queue up for 10,000 boxes of Ai Qingling. Let me check the queue..." Tian Hemeng flipped through his notebook.
"Our company can only produce 50,000 boxes per month, excluding the ones we use. Recently, the Luzon-based Sapiens company purchased 10,000 boxes. You can only wait until next month."
Xie Bin had no objection to this. After all, it was impossible for pharmaceutical companies to expand the production line capacity indefinitely, especially for radical cure drugs like this. Producing a large amount of them all at once would not only destroy the market but would also eventually lead to the rapid retirement of the production line.
Based on the current global population of over 30 million people infected with HIV, plus a portion of those who conceal their infection or are unaware of it, it is estimated that the potential consumer group would reach around 40 million.
If Qingye Medical maintains the production rate of tens of thousands of boxes per month, it will take about 800 months to meet the needs of the global market.
Of course, this is an ideal prediction model.
In fact, the current factory price and retail price of Aiqingling are obviously too high, and some patients simply cannot afford it.
Therefore, Xie Bin is very satisfied that Qingye Medical maintains a supply of tens of thousands of boxes per month.
After all, things are valuable because they are scarce. If you produce millions of boxes at once, the market price will definitely plummet, and the cost will outweigh the gain.
As a qualified businessman, I would never do such a thing.
At the same time, this is also done to prevent European and American pharmaceutical companies from taking desperate measures. After all, their relief drugs can still be sold.
The only places where Aiqingling has been approved for sale are Hongsavady, Siam and Luzon. Other places will probably have to wait for a while.
Especially in Europe and the United States, in fact, major pharmaceutical companies such as Pfizer and Johnson & Johnson are very grateful for Hongsavadi's gold-dollar trade policy, which has resulted in Qingye Group's drugs being unable to enter the European and American markets in a short period of time.
After Xie Bin and Tian Hemeng signed the contract, they did not rush back to Siam, but continued to negotiate other business.
For example, Qingye Medical plans to purchase a batch of medicines and production lines produced by Zhengda Company.
After all, in this new contract, CP Group needs to pay 502.5 million yuan to Qingye Medical. It is impossible for CP Group to use gold for such a large sum of money, so it can only use product replacement.
This time, Qingye Medical has set its sights on Zhengda Company's general medicines and production lines.
Even a second-hand production line will do. Qingye Medical does not have a good relationship with European and American pharmaceutical companies and equipment manufacturing areas, so it can only pick up Zhengda’s second-hand production line.
Anyway, there are only some drugs that can cure common diseases, and developing them by yourself would waste time and money, so you might as well buy a ready-made production line.
